Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent

Patent metadata

Field	Value
Publication number	US-10376466-B2
Application number	US-201816151707-A
Country	US
Kind code	B2
Filing date	Oct 4, 2018
Priority date	Feb 22, 2006
Publication date	Aug 13, 2019
Grant date	Aug 13, 2019

Abstract

Methods are provided for drying a particle. Specifically, there is provided a spray-dried diketopiperazine-insulin particle formulation having improved aerodynamic performance and in which the active agent is more stabile and efficiently delivered as compared to that of the lyophilized diketopiperazine-insulin formulation. The dry powders have utility as pharmaceutical formulations for pulmonary delivery.

First claim

What is claimed is:

1. A method for delivering an active agent to a patient in need thereof using a reusable inhaler, comprising administering by inhalation to the patient an effective amount of a dry powder medicant; wherein said dry powder medicament exhibits an improved pharmaceutic property, and whose formulation comprises the following steps: a) a step for forming microparticles comprising a diketopiperazine with acidic or basic side chains, resulting in a suspension of microparticles of the diketopiperazine with acidic or basic side chains in a solvent, and a step for loading said microparticles with an active agent, then b) removing solvent by spray drying to obtain a dry powder, wherein the dry powder has an improved pharmaceutic property as compared to a dry powder obtained by removing solvent by lyophilization, and wherein the improved pharmaceutic property is increased density of the powder, increased aerodynamic performance of the powder, or improved stability of the active agent, if present.

2. A method for forming a dry powder medicament with an improved pharmaceutic property, comprising: a) a step for forming microparticles comprising a diketopiperazine with acidic or basic side chains, resulting in a suspension of microparticles of the diketopiperazine with acidic or basic side chains in a solvent, and optionally a step for loading said microparticles with an active agent, then b) removing solvent by spray drying to obtain a dry powder having 1.7 to 2.3 times increased density compared to lyophilization, wherein the dry powder has an improved aerodynamic performance of the microparticle.

3. The method of claim 2 , wherein said increased density comprises greater tapped density.

4. The method of claim 2 , wherein said increased density comprises greater bulk density.

5. The method of claim 3 , wherein said greater tapped density is from 0.25 to 0.30 g/cc.

6. The method of claim 4 , wherein said greater bulk density is from 0.15 to 0.20 g/cc.

Assignees

• Mannkind Corp

Inventors

• Wilson Bryan R
• Grant Marshall

Classifications

• A61P3/10

  for hyperglycaemia, e.g. antidiabetics · CPC title

• A61K38/28

  Insulins · CPC title

• A61K9/1694

  resulting in granules or microspheres of the matrix type containing more than 5% of excipient · CPC title

• A61K9/1617

  Organic compounds, e.g. phospholipids, fats · CPC title

• A61K9/0075 Primary

  for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles · CPC title